{"id":"F2023L01430","name":"Statement of Principles concerning malignant neoplasm of the salivary gland (Reasonable Hypothesis) (No. 102 of 2023)","slug":"statement-of-principles-concerning-malignant-neoplasm-of-the-salivary-gland-reasonable-hypothesis-no","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":442140,"registerId":"F2023L01430-fast-fetch-1775957229511","compilationNumber":null,"startDate":"2026-04-12","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Statement of Principles concerning malignant neoplasm of the salivary gland (Reasonable Hypothesis) (No. 102 of 2023)","content":"---\nmeta-content-style-type: text/css\nmeta-content-type: application/xhtml+xml; charset=utf-8\n---\n\n?xml version=\"1.0\" encoding=\"utf-8\" standalone=\"no\"?>\n\n\n\n \n\nStatement of Principles\n\nconcerning\n\nMALIGNANT NEOPLASM OF THE SALIVARY GLAND (Reasonable Hypothesis)\n\n(No. 102 of 2023)\n\nThe Repatriation Medical Authority determines the following Statement of Principles under subsection 196B(2) of the Veterans' Entitlements Act 1986.\n\n \n\nDated 25 October 2023.\n\n \n\n \n\n \n\n \n\n \n\n| The Common Seal of the Repatriation Medical Authority was affixed to this instrument at the direction of:
|\n| --- |\n|
Professor Terence Campbell AM
Chairperson
|\n\n\n \n\n \n\n\nContents\n\n1 Name\n\n2 Commencement\n\n3 Authority\n\n4 Repeal\n\n5 Application\n\n6 Definitions\n\n7 Kind of injury, disease or death to which this Statement of Principles relates\n\n8 Basis for determining the factors\n\n9 Factors that must exist\n\n10 Relationship to service\n\n11 Factors referring to an injury or disease covered by another Statement of Principles\n\nSchedule 1 - Dictionary\n\n1 Definitions\n\n \n\n\n\n\n1 Name\n\nThis is the Statement of Principles concerning malignant neoplasm of the salivary gland (Reasonable Hypothesis) (No. 102 of 2023).\n\n2 Commencement\n\n This instrument commences on 28 November 2023.\n\n3 Authority\n\nThis instrument is made under subsection 196B(2) of the Veterans' Entitlements Act 1986.\n\n4 Repeal\n\nThe Statement of Principles concerning malignant neoplasm of the salivary gland No. 57 of 2015 (Federal Register of Legislation No. F2015L00252) made under subsections 196B(2) and (8) of the VEA is repealed.\n\n5 Application\n\nThis instrument applies to a claim to which section 120A of the VEA or section 338 of the Military Rehabilitation and Compensation Act 2004 applies.\n\n6 Definitions\n\nThe terms defined in the Schedule 1 - Dictionary have the meaning given when used in this instrument.\n\n7 Kind of injury, disease or death to which this Statement of Principles relates\n\n(1) This Statement of Principles is about malignant neoplasm of the salivary gland and death from malignant neoplasm of the salivary gland.\n\nMeaning of malignant neoplasm of the salivary gland\n\n(2) For the purposes of this Statement of Principles, malignant neoplasm of the salivary gland:\n\n(a) means a primary malignant neoplasm arising from the epithelial cells of the major salivary glands (parotid, submandibular and sublingual glands), minor salivary glands or salivary gland ducts; and\n\n(b) excludes:\n\n(i) carcinoid tumour;\n\n(ii) haematolymphoid tumours including non-Hodgkin lymphoma and Hodgkin lymphoma; and\n\n(iii) soft tissue sarcoma.\n\nDeath from malignant neoplasm of the salivary gland\n\n(3) For the purposes of this Statement of Principles, malignant neoplasm of the salivary gland, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's malignant neoplasm of the salivary gland.\n\nNote: terminal event is defined in the Schedule 1 – Dictionary.\n\n8 Basis for determining the factors\n\nThe Repatriation Medical Authority is of the view that there is sound medical‑scientific evidence that indicates that malignant neoplasm of the salivary gland and death from malignant neoplasm of the salivary gland can be related to relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces under the VEA, or members under the MRCA.\n\nNote: MRCA, relevant service and VEA are defined in the Schedule 1 – Dictionary.\n\n9 Factors that must exist\n\nAt least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting malignant neoplasm of the salivary gland or death from malignant neoplasm of the salivary gland with the circumstances of a person's relevant service:\n\n(1) having received a cumulative equivalent dose of at least 0.1 sievert of ionising radiation to the salivary gland at least 5 years before the clinical onset of malignant neoplasm of the salivary gland;\n\nNote: cumulative equivalent dose is defined in the Schedule 1 – Dictionary.\n\n(2) undergoing ablative treatment with radioactive iodine for thyroid cancer before the clinical onset of malignant neoplasm of the salivary gland, where the first exposure occurred at least 5 years before the clinical onset of malignant neoplasm of the salivary gland;\n\n(3) for lymphoepithelial carcinoma of the salivary gland only, having infection with Epstein-Barr virus before the clinical onset of malignant neoplasm of the salivary gland;\n\nNote: infection with Epstein-Barr virus is defined in the schedule 1 dictionary.\n\n(4) having infection with human immunodeficiency virus before the clinical onset of malignant neoplasm of the salivary gland;\n\n(5) having smoked tobacco products in an amount of at least 20 pack-years at least 5 years before the clinical onset of malignant neoplasm of the salivary gland;\n\nNote: one pack-year is defined in the Schedule 1 – Dictionary.\n\n(6) inability to obtain appropriate clinical management for malignant neoplasm of the salivary gland before the clinical worsening of malignant neoplasm of the salivary gland.\n\n10 Relationship to service\n\n(1) The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.\n\n(2) The factor set out in subsection 9(6) applies only to material contribution to, or aggravation of, malignant neoplasm of the salivary gland where the person's malignant neoplasm of the salivary gland was suffered or contracted before or during (but did not arise out of) the person's relevant service.\n\n11 Factors referring to an injury or disease covered by another Statement of Principles\n\nIn this Statement of Principles:\n\n(1) if a factor referred to in section 9 applies in relation to a person; and\n\n(2) that factor refers to an injury or disease in respect of which a Statement of Principles has been determined under subsection 196B(2) of the VEA;\n\nthen the factors in that Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.\n\n \n\n \n\nSchedule 1 - Dictionary \n\nNote: See Section 6\n\n1 Definitions\n\nIn this instrument:\n\n cumulative equivalent dose means the total dose of ionising radiation received by the particular organ or tissue from external exposure, internal exposure or both, apart from normal background radiation exposure in Australia, calculated in accordance with the methodology set out in Guide to calculation of 'cumulative equivalent dose' for the purpose of applying ionising radiation factors contained in Statements of Principles determined under Part XIA of the Veterans' Entitlements Act 1986 (Cth), Australian Radiation Protection and Nuclear Safety Agency, as in force on 2 August 2017.\n\nNote 1: Examples of circumstances that might lead to exposure to ionising radiation include being present during or subsequent to the testing or use of nuclear weapons, undergoing diagnostic or therapeutic medical procedures involving ionising radiation, and being a member of an aircrew, leading to increased levels of exposure to cosmic radiation.\n\nNote 2: For the purpose of dose reconstruction, dose is calculated as an average over the mass of a specific tissue or organ. If a tissue is exposed to multiple sources of ionising radiation, the various dose estimates for each type of radiation must be combined.\n\n infection with Epstein-Barr virus means having serological evidence of infection with Epstein-Barr virus.\n\n malignant neoplasm of the salivary gland—see subsection 7(2).\n\n MRCA means the Military Rehabilitation and Compensation Act 2004.\n\n one pack-year means the amount of tobacco consumed in smoking 20 cigarettes per day for a period of 1 year, or an equivalent amount of tobacco products. \n\n Note 1: An equivalent amount of tobacco products is 7,300 grams of smoking tobacco by weight, either in cigarettes, pipe tobacco or cigars, or a combination of same. For pipe tobacco, cigars or combinations of multiple tobacco types, 1 gram of tobacco is considered to be equal to one cigarette. \n\nNote 2: Pack-years are calculated by dividing the number of cigarettes smoked per day by 20 and multiplying this number by the number of years the person has smoked. For example, smoking 10 cigarettes per day for 10 years is equal to 5 pack-years, and smoking 40 cigarettes per day for 10 years is equal to 20 pack-years.\n\n relevant service means:\n\n(a) operational service under the VEA;\n\n(b) peacekeeping service under the VEA;\n\n(c) hazardous service under the VEA;\n\n(d) British nuclear test defence service under the VEA;\n\n(e) warlike service under the MRCA; or\n\n(f) non-warlike service under the MRCA.\n\nNote: MRCA and VEA are also defined in the Schedule 1 - Dictionary.\n\n terminal event means the proximate or ultimate cause of death and includes the following:\n\n(a) pneumonia;\n\n(b) respiratory failure;\n\n(c) cardiac arrest;\n\n(d) circulatory failure; or\n\n(e) cessation of brain function.\n\n VEA means the Veterans' Entitlements Act 1986.\n\n \n\n \n","sortOrder":0}],"analysis":{"kimi_summary":{"content_quality":"ok","complexity_score":4,"scope_assessment":{"changed":false,"description":"This is a standard replacement instrument maintaining the established scope of Repatriation Medical Authority Statements of Principles. It updates the 2015 version without expanding beyond the original purpose of establishing medical criteria for service-related compensation claims."},"complexity_factors":["Multiple defined terms requiring cross-reference to Schedule 1 (7 explicit definitions plus incorporated terms)","Nested temporal conditions (e.g., 'at least 5 years before the clinical onset' appears in 3 of 6 factors)","Factor-specific limitations (factor 3 applies only to lymphoepithelial carcinoma; factor 6 applies only to pre-existing conditions)","External document incorporation by reference (ARPRSA methodology guide for radiation dose calculation dated 2 August 2017)","Dual legislative framework application (VEA and MRCA with different service categories)","Mathematical calculation requirements for pack-years and sievert measurements","Cross-referencing mechanism in section 11 linking to other Statements of Principles"],"plain_english_summary":"This instrument replaces the 2015 version and sets medical criteria for when salivary gland cancer is treated as service-related for compensation. It creates a \"reasonable hypothesis\" standard (lower than proving direct causation) based on six medical factors.\n\nIt affects veterans and current/former defence members who served in operations, peacekeeping, hazardous service, or nuclear tests and applies to claims under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004."},"flash_summary":{"complexity_score":6,"scope_assessment":{"changed":true,"description":"This instrument expressly repeals and replaces the 2015 Statement of Principles (s4) and takes effect on 28 November 2023 (s2). It narrows the mechanistic pathway for a reasonable hypothesis by specifying particular qualifying factors and thresholds (notably a 0.1 sievert radiation threshold, defined smoking pack‑years, specified infections, radioactive iodine therapy and inability to obtain appropriate clinical management) that must be related to relevant service for a claim (s9, s10, Schedule). The practical scope of claims will therefore be determined against these updated, technical criteria and their evidentiary requirements (s5, s11)."},"complexity_factors":["Technical medical thresholds and exclusions (definition of malignant neoplasm; exclusions in s7(2); specialised diagnoses such as lymphoepithelial carcinoma in s9(3)).","Dose reconstruction and radiation science requirement (cumulative equivalent dose threshold at s9(1) and detailed calculation methodology referenced in the Schedule's definition of cumulative equivalent dose).","Multiple distinct causal factors with differing evidentiary standards (radiation, radioactive iodine therapy, serology for Epstein–Barr virus, HIV status, quantified smoking history, and clinical management issues — s9 and Schedule definitions).","Temporal qualification requirements (minimum 5‑year latency for several factors at s9(1), s9(2), s9(5)), affecting proof and medical chronology.","Interplay with other Statements of Principles (s11) — overlapping injuries/diseases may invoke different or additional rules, adding legal interaction complexity.","Application limited to specific claim pathways (section 120A VEA and section 338 MRCA) so procedural/eligibility complexity for claimants (s5).","Administrative discretion and standard‑setting by the Repatriation Medical Authority (authority under s3; basis statement at s8), creating dependence on RMA determinations and published guides.","Evidence and compliance burdens on claimants (requirement to establish exposures, serology, pack‑year histories, or lack of clinical management; Schedule definitions clarify measurement methods but increase documentary requirements)."],"plain_english_summary":"This instrument replaces the prior Statement of Principles for malignant salivary gland cancer and sets the medical criteria that can raise a “reasonable hypothesis” linking that cancer (or death from it) to a person’s military or peacekeeping service (ss2,4,5,7). It lists specific service‑related factors — e.g. ionising radiation (≥0.1 sievert), radioactive iodine therapy, certain infections, high lifetime tobacco exposure, or lack of appropriate clinical management — that, if evidenced, may support a veteran’s claim under the VEA or MRCA (s9, Schedule)."},"flash_summary_failed":{"failed":true,"reason":"A positive credit balance is required for all requests, including BYOK, so fallback providers remain available. Add credits at https://vercel.com/d?to=%2F%5Bteam%5D%2F%7E%2Fai%3Fmodal%3Dtop-up to continue.","source":"analysis-cron"}},"importantCases":[],"_links":{"self":"/api/acts/statement-of-principles-concerning-malignant-neoplasm-of-the-salivary-gland-reasonable-hypothesis-no","history":"/api/acts/statement-of-principles-concerning-malignant-neoplasm-of-the-salivary-gland-reasonable-hypothesis-no/history","analysis":"/api/acts/statement-of-principles-concerning-malignant-neoplasm-of-the-salivary-gland-reasonable-hypothesis-no/analysis","conflicts":"/api/acts/statement-of-principles-concerning-malignant-neoplasm-of-the-salivary-gland-reasonable-hypothesis-no/conflicts","importantCases":"/api/acts/statement-of-principles-concerning-malignant-neoplasm-of-the-salivary-gland-reasonable-hypothesis-no/important-cases","documents":"/api/acts/statement-of-principles-concerning-malignant-neoplasm-of-the-salivary-gland-reasonable-hypothesis-no/documents"}}